Description
Herceptin 600mg/5mL (1 vial) is a subcutaneous (under the skin) formulation of Trastuzumab. It is a targeted biological therapy manufactured by Roche, primarily used to treat HER2-positive breast cancer and metastatic gastric cancer. [1, 2]
Core Product Description
- Physical Appearance: Comes as a clear to opalescent, colourless to yellowish solution for injection in a single-use glass vial. [1]
Indications
Herceptin is prescribed for:
- HER2-Positive Early and Metastatic Breast Cancer: Used alone or combined with standard chemotherapy.
Storage Requirements
- Temperature: Must be refrigerated between 2°C and 8°C.
- Protection: Keep the vial in the outer carton to protect it from light.
- Handling: Do not freeze. Once opened, it should be used immediately.

Reviews
There are no reviews yet.